SlideShare a Scribd company logo
1 of 36
Quality Risk Assessment
Hardik Mistry - Quality Assurance
 Quality Risk Assessment
 Environmental Risk Assessment
 OHSAS relates Risk Assessment (HIRA)
Risk Assessment
 Quality Risk Management is a systematic process for the assessment,
control, communication, and review of risks to the quality of the product
across the product lifecycle.
 Quality management is a valuable component of an effective quality system.
 Key Player in the Life Cycle Approach.
Objective
This procedure is applicable to the Quality Risk Management of,
Products manufactured at the Hester Bioscience Limited.
Man & Material Movement in Manufacturing
Equipments, Systems, Utilities and Facility etc.
Out of Specification investigations.
QC TP
Out of Trend Investigations.
Deviation Investigation.
Documentation Procedure
Change control
Market Complaints investigations.
Self inspection.
Scope
 Departmental Heads, Process and System owners are responsible for the
ensuring that risks to quality, compliance and other site functions are
considered, understood and managed to an appropriate level.
 They must ensure that a suitable Quality Risk Management process is
implemented and that appropriate inputs with the necessary competence
are involved.
 Final approval of the quality assessment should be done by the head of the
Quality Assurance.
Responsibility
Reference
 ICH Q9 : Quality risk management , Current step 4 , Version November 2005.
 Impact assessment of guidance for Industry, process validation: General
Principles and practices, CDER, USFDA, January 2011.
 PICs guideline PE009-9 Annex 20 “Quality Risk Management”.
 WHO Technical Report Series No. 981; 2013, Annexure 2 “Quality Risk
Management.”
 Orange book - Rules and guidance for pharmaceutical manufacturers and
distributers 2015, EU Guidance on good manufacturing practices; Chapter 1
“Pharmaceutical Quality System”; Section 1.12 -1.13 “Quality Risk
Management.”
 21 CFR (Code of federal regulation), part 211.67
Flow Diagram of the Quality Risk Assessment Process
 A systematic use of objective evidence to identify quality risk through
processes like collection and organizing information, reviewing appropriate
references and identifying assumptions.
 The information required to risk identification shall be gathered from
questions like :
 What might go wrong?
 What is the likelihood it will go wrong?
 What are the consequences?
1.0 Risk Identification
 Do Risk analysis for each Identified Risk
 Severity
 Occurrence or Probability
 Control
2.0 Risk Analysis
Evaluate the Risk based on the Risk Analysis
Risk is to be either
 Major
 Minor
 Critical
For Evaluated Risk
 Controls available
 Uncontrolled condition
 Improvement in Controls
 Additional Controls required.
3.0 Risk Evaluation
Decision shall be made based on evaluation of the below questions:
 Is the risk above an acceptable level?
 What can be done to reduce or eliminate risks?
 What is the appropriate balance among benefits, risks and resources?
 Are new risks introduced as a result of the identified risks being
controlled?
Acceptance of the residual risk shall be addressed in risk assessment report.
4.0 Risk Control & Risk Reduction
 During risk control activities the following key questions to be
 What can be done to reduce or eliminate risks?
 What is the appropriate balance between benefits, risks and
resources?
 Are new risks introduced as a result of the identified risks being
controlled?
 Risk control can include:
 not proceeding with the risky activity;
 taking the risk;
 removing the risk source;
 changing the likelihood of the risk;
 changing the consequences of the risk;
 sharing the risk with another party (e.g. contractor);
 retaining the risk by informed decision.
Risk management for new product manufacturing
Risk management for Site Transfer Product manufacturing
Risk Management for Aseptic Manufacturing Process
 FMEA format and shall be based on the potential variables that
can affect Sterility Assurance of Product, Endotoxin level,
Particulate count. (For us vaccine safety, efficacy, purity)
 The risk assessment shall be based on personnel, material,
equipment, components, environment and utility control. (5 M)
 Critical parameter such as aseptic process simulation (media
fill), smoke test study, personnel, environment, material
movement, process, equipments, utility and any direct impact
on aseptic process/sterility assurance shall be considered.
Risk Management for Aseptic Manufacturing Process
 Incidents/events, Market complaints, Batch failure investigations, process
/ Analytical trend monitoring, Audits, Change control related to aseptic
manufacturing process shall be reviewed as a part of risk assessment
process to identify the potential variables that can affect sterility
assurance of product, endotoxin level, particulate count and ultimately the
risk at the end use.
 The risk assessment reports shall be prepared by concerned department,
reviewed by concerned department head to which the risk is concerned
and approved by QA.
 Subsequent to process validations, Critical Quality attributes (CQA) shall
be monitored through APR. based on the frequent failure in controlled
system Risk Assessment is to be revised.
 Give the number of risk assessment in the format of HBL/RA/00N/YY
00N is serial number of Risk Assessment & YY is revision number of RA. If its
first version then no need to mention it.
 Title of Risk assessment : Title of Risk Assessment for which number is to be
assigned.
 Type of Risk assessment : The type for which risk assessment is assigned shall
be mentioned. Type includes Product / System / Equipment / Instrument /
Machine / Utility/ Material / Other.
 Risk assessment Number : Allotted number to be shall be mentioned.
 Effective on : Date on which the risk assessment report is approved shall be
mentioned.
 Year : Year of risk assessment number allocation shall be mentioned.
 Remarks : Remark shall be written if any. In case of no remark “None” shall be
recorded.
Procedure for risk assessment document numbering
Three factors shall be considered when assessing the level of risk
 Severity / Impact of Risk
 Probability of Occurrence
 Probability of Detection (State of Controls)
S O C
SEVERITY
Quantitative
Rating
Qualitative
Rating
Criteria
1-2
(Low)
Low
· No impact on product identity, strength, purity and quality
· Minor GMP non-compliance
· No impact on user safety (defects which may not pose any
significant hazard to health)
3-4
(Medium)
Medium
· Likely impact on product identity, strength, purity and quality
· Major GMP non-compliance
· Potential impact on user safety (defects which could cause
illness or mistreatment but are not life threatening or serious
ones or are medically Reversible)
5-6
(High)
High
· Direct impact on product identity, strength, purity and quality
· Critical GMP non-compliance
· Critical impact on user t safety (defects which are potentially
life-threatening or could cause serious risk to health)
Severity Assessment
Example of the Risk Assessment of Initiation of Deviation
Assessment of Probability of Occurrence (O) of the Cause
PROBABILITY OF OCCURRENCE
Quantitative
Rating
Qualitative Rating Criteria
1-2 (Low) Low
The quality related event is unlikely to occur. (i.e.
it has not occurred in the past and is not expected
to occur or recur)
3-4 (Medium) Medium
The quality related event may occur (i.e. It has
occurred infrequently in the past and is expected
to recur)
5-6 (High) High
The quality related event is likely to occur (i.e. it
has occurred in the past on a frequent basis and is
definitely expected to occur again).
Example of the Risk Assessment of Initiation of Deviation
Risk rating based on probability of occurrence
Risk rating
based on
severity
Low Medium High NA
High Level-1 Level-1 Level-1 Level-1
Medium Level-2 Level-2 Level-1 Level-2
Low Level-3 Level-3 Level-2 Level-3
NA Level-3 Level-3 Level-2 NA
Assessment of the ‘Probability of Detection (D) (or ‘State of Control’)
DETECTION
Quantitative Rating Qualitative Rating Criteria
5-6
(Weak)
Weak
The Quality System has either ‘weak’ or ‘no’ controls to
detect the quality related event after its occurrence and
prevent it from recurring, e.g. systems are non validated or
with perception based evaluation techniques, process
controls are dependent on human efficiency, etc.
There is a low chance the current controls will detect the
quality event after its occurrence.
3-4
(Medium)
Medium
The system has controls and will possibly detect the
quality related event after its occurrence.
1-2
(Strong)
Strong
The system has multiple controls and is very likely to
detect the quality related event after its occurrence.
Final Risk Classification
Rating – Probability of Detection
Risk level based
on severity &
probability of
occurrence
Strong Medium Weak NA
Level-1 Major Critical Critical Critical
Level-2 Minor Major Critical Critical
Level-3 Minor Minor Major Major
NA Un-classified Un-classified Un-classified Un-classified
Significance of Risk Priority Number (RPN = SxOxD )
Risk Priority Number
Risk Category
Nature of
impact
Acceptance criteria & Mitigation
(action) statusRisk on Product
Risk on people/
Facility/
Organization
< 20 < 25 Minor Non impact
Risk is acceptable.
No mitigation is required
< 60 < 75 Major Indirect impact
Acceptable with control
/explanation of control.
≥ 60 ≥ 75 Critical Direct Impact
Requires additional control
measure before acceptance
Risk Evaluation
 Is the risk above an acceptable level?
 What can be done to reduce or eliminate risks?
 What is the appropriate balance among benefits, risks and resources?
 Are new risks introduced as a result of the identified risks being controlled?
Risk Control/ Mitigation
Control Measures/CAPA shall be considered for risk control/ mitigation and
shall be implemented using applicable procedures for the same. Such
actions shall be prioritized to control/ mitigate the risk or reduce it to an
acceptable level.
Assessment of Risk Level and Its Mitigation
Sr.No Potential Failure Mode/ Type of problem RPN Number Level of Risk Risk Mitigation
Reference
Document No
1. GMP document is to be prepare in A4 size paper approved uniform format. 3 Minor
NA Process is under Control NA
2.
SOP is to be clear, unambiguous language, easy to understand and easy to
follow.
12 Minor
3.
Concerned department person has to filled Change control form for the
preparation of the new GMP document.
3 Minor
4.
For the preparation of the GMP document Draft copy is to be prepared and
send to Quality assurance department for review.
3 Minor
5.
Subject matter expert from the concerned department can prepare SOP if
he or she is trained for the SOP. Officer, executive or concerned person who
has expertise in subject of SOP can review and signed as checked by.
9 Minor
6.
GMP document numbering is to be done by Quality Assurance department
and as per the Master Document numbering guide.
9 Minor
7.
Once the document is reviewed and approved and respective change
control is closed then QA person will stamp signed and approved GMP
document as Master Copy in red color at the bottom right corner and retain
it as Master in QA document archival.
6 Minor
8.
QA person will make the no of required photocopies of the GMP document
from the Master Copy and stamp as CONTROLLED COPY or UNCONTROLLED
COPY as required for issuance.
2 Minor
9.
In case of the GMP records QA person will take print in black and white and
stamp as CONTROLLED COPY or UNCONTROLLED COPY for issuance.
2 Minor
10
If any change is required in the GMP document, concerned person will
fill change control and follow the change control procedure. 45 Major
SOP HBl-QAD-1001-01-02 is
to be revised Controlled copy
must be photocopied of the
scan signed approved master
copy.
Each issued controlled copy
of record must have
identification number.
Ref CAPA :
_______
Risk Reduction may be achieved by (but not limited to):
 Improvement in the quality of the product by design
- this may include improvement in the process,
procedures, control measures, monitoring.
 Change of process and / or procedures.
 Revision of specification to stringent limits.
 Improvement of periodicity of the measurement of
parameters.
 Change in the frequency of calibration, qualification,
validation, quality system internal audits in order to
proactively identify the chances of the risk.
Risk Reduction
Risk assessment tools
Following risk assessment tools can be used for performing risk assessment, but not limited to:
 Flow Charting
 Brainstorming
 Process Mapping
 Statistical Tools
 Risk Ranking & Filtering
 Preliminary Hazard Analysis (PHA)
 Root Cause Analysis
 Ishikawa or Fish Bone Diagrams
 FMEA (Failure Mode and Effects Analysis)/FMECA (Failure Mode Effects and Criticality
Analysis)
 HACCP (Hazard Analysis and Critical Control Points)
 Variation Risk Management
 Probabilistic Risk Analysis
 Decision Trees
 Event Tree Analysis
 FTA (Fault Tree Analysis)
QUALITY SYSTEMS FOR WHICH RISK ASSESSMENT IS TO BE PERFORMED
Sr.No Risk Assessment is to be Performed Department/Section TCD
1 Deviation Handling Procedure Quality Assurance
2 Change Control Procedure Quality Assurance
3 DocumentationSystem Quality Assurance
4 Vendor Audit & Approval Quality Assurance
EQUIPMENT & UTILITY FOR WHICH RISK ASSESSMENT IS TO BE PERFORMED
Sr.No Risk Assessment is to be Performed Department/Section TCD
1 Water System Engineering
2 PSG Engineering
3 Compressed Air Engineering
4 Autoclave Engineering
5 DHS Engineering
6 Incubator Engineering
7 Lyophilizer Engineering
Pharmaceutical Quality Risk Assessment

More Related Content

What's hot

BMR (Batch Manufacturing Record)
BMR (Batch Manufacturing Record)BMR (Batch Manufacturing Record)
BMR (Batch Manufacturing Record)
Ram Mohan S R
 

What's hot (20)

change control
change controlchange control
change control
 
Six system inspection model
Six system inspection modelSix system inspection model
Six system inspection model
 
BPR review and batch release
BPR review and batch release BPR review and batch release
BPR review and batch release
 
Quality Risk Management
Quality Risk ManagementQuality Risk Management
Quality Risk Management
 
PROCESS VALIDATION
PROCESS VALIDATIONPROCESS VALIDATION
PROCESS VALIDATION
 
Change control
Change controlChange control
Change control
 
CHAPTER-1 DEFICIENCIES.pdf
CHAPTER-1 DEFICIENCIES.pdfCHAPTER-1 DEFICIENCIES.pdf
CHAPTER-1 DEFICIENCIES.pdf
 
Cleaning validation a complete know how
Cleaning validation a complete know howCleaning validation a complete know how
Cleaning validation a complete know how
 
Deviation, OOS & complaint investigation and CAPA
Deviation, OOS & complaint investigation and CAPADeviation, OOS & complaint investigation and CAPA
Deviation, OOS & complaint investigation and CAPA
 
Principle of Validation and Qualification
Principle of Validation and QualificationPrinciple of Validation and Qualification
Principle of Validation and Qualification
 
Change control oos oot
Change control oos ootChange control oos oot
Change control oos oot
 
Risk management in pharmaceutical Industry
Risk management in pharmaceutical IndustryRisk management in pharmaceutical Industry
Risk management in pharmaceutical Industry
 
Fundamental of cleaning validation
Fundamental of cleaning validationFundamental of cleaning validation
Fundamental of cleaning validation
 
Validation master plan
Validation master planValidation master plan
Validation master plan
 
Process Validation.pdf
Process Validation.pdfProcess Validation.pdf
Process Validation.pdf
 
Cleaning validation
Cleaning validationCleaning validation
Cleaning validation
 
BMR (Batch Manufacturing Record)
BMR (Batch Manufacturing Record)BMR (Batch Manufacturing Record)
BMR (Batch Manufacturing Record)
 
Pharmaceutical process validation (PV)
Pharmaceutical process validation (PV)  Pharmaceutical process validation (PV)
Pharmaceutical process validation (PV)
 
Qualification & Validation
Qualification & ValidationQualification & Validation
Qualification & Validation
 
GMP Training: Handling of deviation
GMP Training: Handling of deviationGMP Training: Handling of deviation
GMP Training: Handling of deviation
 

Similar to Pharmaceutical Quality Risk Assessment

Qrm presentation
Qrm presentationQrm presentation
Qrm presentation
Geetha Svcp
 

Similar to Pharmaceutical Quality Risk Assessment (20)

ICH Q9 QUALITY RISK MANAGEMENT(QRM)
ICH Q9 QUALITY RISK MANAGEMENT(QRM)ICH Q9 QUALITY RISK MANAGEMENT(QRM)
ICH Q9 QUALITY RISK MANAGEMENT(QRM)
 
Quality Risk Management
Quality Risk ManagementQuality Risk Management
Quality Risk Management
 
Quality risk management
Quality risk managementQuality risk management
Quality risk management
 
Risk management and environmental monitoring
Risk management and environmental monitoringRisk management and environmental monitoring
Risk management and environmental monitoring
 
Presentation on QRM
Presentation on QRMPresentation on QRM
Presentation on QRM
 
Quality Risk Management
Quality Risk ManagementQuality Risk Management
Quality Risk Management
 
Quality risk management
Quality risk managementQuality risk management
Quality risk management
 
Quality Risk Management 2 brief note
Quality  Risk Management 2 brief noteQuality  Risk Management 2 brief note
Quality Risk Management 2 brief note
 
ASTM Standard E 2500 for Commissioning and Qualifications
ASTM Standard E 2500 for Commissioning and QualificationsASTM Standard E 2500 for Commissioning and Qualifications
ASTM Standard E 2500 for Commissioning and Qualifications
 
Application of Q R M in Manufacturing Operations
Application of Q R M in Manufacturing Operations Application of Q R M in Manufacturing Operations
Application of Q R M in Manufacturing Operations
 
Quality Risk Managemment ICH Q9
Quality Risk Managemment ICH Q9Quality Risk Managemment ICH Q9
Quality Risk Managemment ICH Q9
 
Quality Risk Management Dr.A. Amsavel
Quality Risk Management   Dr.A. AmsavelQuality Risk Management   Dr.A. Amsavel
Quality Risk Management Dr.A. Amsavel
 
Quality Risk Management - Dr.A. Amsavel
Quality Risk Management  - Dr.A. AmsavelQuality Risk Management  - Dr.A. Amsavel
Quality Risk Management - Dr.A. Amsavel
 
QRM in drug analysis group Assignment.pptx
QRM in drug analysis group Assignment.pptxQRM in drug analysis group Assignment.pptx
QRM in drug analysis group Assignment.pptx
 
Quality risk management by talha usmani
Quality risk management by talha usmaniQuality risk management by talha usmani
Quality risk management by talha usmani
 
Analytical control strategy 2
Analytical control strategy 2Analytical control strategy 2
Analytical control strategy 2
 
Application of Quality Risk Management in Commissioning & Qualifcation
Application of Quality Risk Management in Commissioning & QualifcationApplication of Quality Risk Management in Commissioning & Qualifcation
Application of Quality Risk Management in Commissioning & Qualifcation
 
Qrm presentation
Qrm presentationQrm presentation
Qrm presentation
 
Quality Risk Management.pptx
Quality Risk Management.pptxQuality Risk Management.pptx
Quality Risk Management.pptx
 
Quality risk management
Quality risk managementQuality risk management
Quality risk management
 

More from Pharmaceutical

More from Pharmaceutical (15)

Pharmaceutical Qualification & Validation
Pharmaceutical Qualification & ValidationPharmaceutical Qualification & Validation
Pharmaceutical Qualification & Validation
 
Pharmaceutical Good Manufacturing Practices
Pharmaceutical Good Manufacturing PracticesPharmaceutical Good Manufacturing Practices
Pharmaceutical Good Manufacturing Practices
 
Good Aseptic Practices ppt
Good Aseptic Practices  pptGood Aseptic Practices  ppt
Good Aseptic Practices ppt
 
DATA INTEGRITY GMP COMPLIANCE
DATA INTEGRITY GMP COMPLIANCEDATA INTEGRITY GMP COMPLIANCE
DATA INTEGRITY GMP COMPLIANCE
 
F sterility failure
F sterility failureF sterility failure
F sterility failure
 
ALKANES
ALKANESALKANES
ALKANES
 
New Approches towards the Anti-HIV chemotherapy
New Approches towards the Anti-HIV chemotherapyNew Approches towards the Anti-HIV chemotherapy
New Approches towards the Anti-HIV chemotherapy
 
Methane
MethaneMethane
Methane
 
Role Of Solvent
Role Of Solvent Role Of Solvent
Role Of Solvent
 
Molecular modelling
Molecular modelling Molecular modelling
Molecular modelling
 
QUALITY ASSURANCE
QUALITY ASSURANCEQUALITY ASSURANCE
QUALITY ASSURANCE
 
SAMPLING METHODS
SAMPLING METHODS SAMPLING METHODS
SAMPLING METHODS
 
TOOLS OF CONTINUOUS IMPROVEMENT
TOOLS OF CONTINUOUS IMPROVEMENTTOOLS OF CONTINUOUS IMPROVEMENT
TOOLS OF CONTINUOUS IMPROVEMENT
 
SOP
SOPSOP
SOP
 
Good documentation practice
Good documentation practiceGood documentation practice
Good documentation practice
 

Recently uploaded

👉Chandigarh Call Girl Service📲Niamh 8868886958 📲Book 24hours Now📲👉Sexy Call G...
👉Chandigarh Call Girl Service📲Niamh 8868886958 📲Book 24hours Now📲👉Sexy Call G...👉Chandigarh Call Girl Service📲Niamh 8868886958 📲Book 24hours Now📲👉Sexy Call G...
👉Chandigarh Call Girl Service📲Niamh 8868886958 📲Book 24hours Now📲👉Sexy Call G...
Sheetaleventcompany
 
Call Girl In Indore 📞9235973566📞 Just📲 Call Inaaya Indore Call Girls Service ...
Call Girl In Indore 📞9235973566📞 Just📲 Call Inaaya Indore Call Girls Service ...Call Girl In Indore 📞9235973566📞 Just📲 Call Inaaya Indore Call Girls Service ...
Call Girl In Indore 📞9235973566📞 Just📲 Call Inaaya Indore Call Girls Service ...
Sheetaleventcompany
 
Premium Call Girls Dehradun {8854095900} ❤️VVIP ANJU Call Girls in Dehradun U...
Premium Call Girls Dehradun {8854095900} ❤️VVIP ANJU Call Girls in Dehradun U...Premium Call Girls Dehradun {8854095900} ❤️VVIP ANJU Call Girls in Dehradun U...
Premium Call Girls Dehradun {8854095900} ❤️VVIP ANJU Call Girls in Dehradun U...
Sheetaleventcompany
 
💚Chandigarh Call Girls 💯Riya 📲🔝8868886958🔝Call Girls In Chandigarh No💰Advance...
💚Chandigarh Call Girls 💯Riya 📲🔝8868886958🔝Call Girls In Chandigarh No💰Advance...💚Chandigarh Call Girls 💯Riya 📲🔝8868886958🔝Call Girls In Chandigarh No💰Advance...
💚Chandigarh Call Girls 💯Riya 📲🔝8868886958🔝Call Girls In Chandigarh No💰Advance...
Sheetaleventcompany
 
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan CytotecJual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
jualobat34
 
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
Sheetaleventcompany
 
Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...
Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...
Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...
Sheetaleventcompany
 
Premium Call Girls Nagpur {9xx000xx09} ❤️VVIP POOJA Call Girls in Nagpur Maha...
Premium Call Girls Nagpur {9xx000xx09} ❤️VVIP POOJA Call Girls in Nagpur Maha...Premium Call Girls Nagpur {9xx000xx09} ❤️VVIP POOJA Call Girls in Nagpur Maha...
Premium Call Girls Nagpur {9xx000xx09} ❤️VVIP POOJA Call Girls in Nagpur Maha...
Sheetaleventcompany
 
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
Sheetaleventcompany
 

Recently uploaded (20)

👉Chandigarh Call Girl Service📲Niamh 8868886958 📲Book 24hours Now📲👉Sexy Call G...
👉Chandigarh Call Girl Service📲Niamh 8868886958 📲Book 24hours Now📲👉Sexy Call G...👉Chandigarh Call Girl Service📲Niamh 8868886958 📲Book 24hours Now📲👉Sexy Call G...
👉Chandigarh Call Girl Service📲Niamh 8868886958 📲Book 24hours Now📲👉Sexy Call G...
 
Chandigarh Call Girls Service ❤️🍑 9809698092 👄🫦Independent Escort Service Cha...
Chandigarh Call Girls Service ❤️🍑 9809698092 👄🫦Independent Escort Service Cha...Chandigarh Call Girls Service ❤️🍑 9809698092 👄🫦Independent Escort Service Cha...
Chandigarh Call Girls Service ❤️🍑 9809698092 👄🫦Independent Escort Service Cha...
 
Call Girl In Indore 📞9235973566📞 Just📲 Call Inaaya Indore Call Girls Service ...
Call Girl In Indore 📞9235973566📞 Just📲 Call Inaaya Indore Call Girls Service ...Call Girl In Indore 📞9235973566📞 Just📲 Call Inaaya Indore Call Girls Service ...
Call Girl In Indore 📞9235973566📞 Just📲 Call Inaaya Indore Call Girls Service ...
 
Premium Call Girls Dehradun {8854095900} ❤️VVIP ANJU Call Girls in Dehradun U...
Premium Call Girls Dehradun {8854095900} ❤️VVIP ANJU Call Girls in Dehradun U...Premium Call Girls Dehradun {8854095900} ❤️VVIP ANJU Call Girls in Dehradun U...
Premium Call Girls Dehradun {8854095900} ❤️VVIP ANJU Call Girls in Dehradun U...
 
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
7 steps How to prevent Thalassemia : Dr Sharda Jain & Vandana Gupta
 
Bandra East [ best call girls in Mumbai Get 50% Off On VIP Escorts Service 90...
Bandra East [ best call girls in Mumbai Get 50% Off On VIP Escorts Service 90...Bandra East [ best call girls in Mumbai Get 50% Off On VIP Escorts Service 90...
Bandra East [ best call girls in Mumbai Get 50% Off On VIP Escorts Service 90...
 
💚Chandigarh Call Girls 💯Riya 📲🔝8868886958🔝Call Girls In Chandigarh No💰Advance...
💚Chandigarh Call Girls 💯Riya 📲🔝8868886958🔝Call Girls In Chandigarh No💰Advance...💚Chandigarh Call Girls 💯Riya 📲🔝8868886958🔝Call Girls In Chandigarh No💰Advance...
💚Chandigarh Call Girls 💯Riya 📲🔝8868886958🔝Call Girls In Chandigarh No💰Advance...
 
Intramuscular & Intravenous Injection.pptx
Intramuscular & Intravenous Injection.pptxIntramuscular & Intravenous Injection.pptx
Intramuscular & Intravenous Injection.pptx
 
🚺LEELA JOSHI WhatsApp Number +91-9930245274 ✔ Unsatisfied Bhabhi Call Girls T...
🚺LEELA JOSHI WhatsApp Number +91-9930245274 ✔ Unsatisfied Bhabhi Call Girls T...🚺LEELA JOSHI WhatsApp Number +91-9930245274 ✔ Unsatisfied Bhabhi Call Girls T...
🚺LEELA JOSHI WhatsApp Number +91-9930245274 ✔ Unsatisfied Bhabhi Call Girls T...
 
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan CytotecJual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
 
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
 
Call 8250092165 Patna Call Girls ₹4.5k Cash Payment With Room Delivery
Call 8250092165 Patna Call Girls ₹4.5k Cash Payment With Room DeliveryCall 8250092165 Patna Call Girls ₹4.5k Cash Payment With Room Delivery
Call 8250092165 Patna Call Girls ₹4.5k Cash Payment With Room Delivery
 
Gastric Cancer: Сlinical Implementation of Artificial Intelligence, Synergeti...
Gastric Cancer: Сlinical Implementation of Artificial Intelligence, Synergeti...Gastric Cancer: Сlinical Implementation of Artificial Intelligence, Synergeti...
Gastric Cancer: Сlinical Implementation of Artificial Intelligence, Synergeti...
 
Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...
Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...
Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...
 
💰Call Girl In Bangalore☎️63788-78445💰 Call Girl service in Bangalore☎️Bangalo...
💰Call Girl In Bangalore☎️63788-78445💰 Call Girl service in Bangalore☎️Bangalo...💰Call Girl In Bangalore☎️63788-78445💰 Call Girl service in Bangalore☎️Bangalo...
💰Call Girl In Bangalore☎️63788-78445💰 Call Girl service in Bangalore☎️Bangalo...
 
Premium Call Girls Nagpur {9xx000xx09} ❤️VVIP POOJA Call Girls in Nagpur Maha...
Premium Call Girls Nagpur {9xx000xx09} ❤️VVIP POOJA Call Girls in Nagpur Maha...Premium Call Girls Nagpur {9xx000xx09} ❤️VVIP POOJA Call Girls in Nagpur Maha...
Premium Call Girls Nagpur {9xx000xx09} ❤️VVIP POOJA Call Girls in Nagpur Maha...
 
ANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptxANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptx
 
❤️Call Girl Service In Chandigarh☎️9814379184☎️ Call Girl in Chandigarh☎️ Cha...
❤️Call Girl Service In Chandigarh☎️9814379184☎️ Call Girl in Chandigarh☎️ Cha...❤️Call Girl Service In Chandigarh☎️9814379184☎️ Call Girl in Chandigarh☎️ Cha...
❤️Call Girl Service In Chandigarh☎️9814379184☎️ Call Girl in Chandigarh☎️ Cha...
 
Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...
Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...
Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...
 
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
 

Pharmaceutical Quality Risk Assessment

  • 1. Quality Risk Assessment Hardik Mistry - Quality Assurance
  • 2.  Quality Risk Assessment  Environmental Risk Assessment  OHSAS relates Risk Assessment (HIRA) Risk Assessment
  • 3.  Quality Risk Management is a systematic process for the assessment, control, communication, and review of risks to the quality of the product across the product lifecycle.  Quality management is a valuable component of an effective quality system.  Key Player in the Life Cycle Approach. Objective
  • 4. This procedure is applicable to the Quality Risk Management of, Products manufactured at the Hester Bioscience Limited. Man & Material Movement in Manufacturing Equipments, Systems, Utilities and Facility etc. Out of Specification investigations. QC TP Out of Trend Investigations. Deviation Investigation. Documentation Procedure Change control Market Complaints investigations. Self inspection. Scope
  • 5.  Departmental Heads, Process and System owners are responsible for the ensuring that risks to quality, compliance and other site functions are considered, understood and managed to an appropriate level.  They must ensure that a suitable Quality Risk Management process is implemented and that appropriate inputs with the necessary competence are involved.  Final approval of the quality assessment should be done by the head of the Quality Assurance. Responsibility
  • 6. Reference  ICH Q9 : Quality risk management , Current step 4 , Version November 2005.  Impact assessment of guidance for Industry, process validation: General Principles and practices, CDER, USFDA, January 2011.  PICs guideline PE009-9 Annex 20 “Quality Risk Management”.  WHO Technical Report Series No. 981; 2013, Annexure 2 “Quality Risk Management.”  Orange book - Rules and guidance for pharmaceutical manufacturers and distributers 2015, EU Guidance on good manufacturing practices; Chapter 1 “Pharmaceutical Quality System”; Section 1.12 -1.13 “Quality Risk Management.”  21 CFR (Code of federal regulation), part 211.67
  • 7. Flow Diagram of the Quality Risk Assessment Process
  • 8.  A systematic use of objective evidence to identify quality risk through processes like collection and organizing information, reviewing appropriate references and identifying assumptions.  The information required to risk identification shall be gathered from questions like :  What might go wrong?  What is the likelihood it will go wrong?  What are the consequences? 1.0 Risk Identification
  • 9.  Do Risk analysis for each Identified Risk  Severity  Occurrence or Probability  Control 2.0 Risk Analysis
  • 10. Evaluate the Risk based on the Risk Analysis Risk is to be either  Major  Minor  Critical For Evaluated Risk  Controls available  Uncontrolled condition  Improvement in Controls  Additional Controls required. 3.0 Risk Evaluation
  • 11. Decision shall be made based on evaluation of the below questions:  Is the risk above an acceptable level?  What can be done to reduce or eliminate risks?  What is the appropriate balance among benefits, risks and resources?  Are new risks introduced as a result of the identified risks being controlled? Acceptance of the residual risk shall be addressed in risk assessment report. 4.0 Risk Control & Risk Reduction
  • 12.  During risk control activities the following key questions to be  What can be done to reduce or eliminate risks?  What is the appropriate balance between benefits, risks and resources?  Are new risks introduced as a result of the identified risks being controlled?  Risk control can include:  not proceeding with the risky activity;  taking the risk;  removing the risk source;  changing the likelihood of the risk;  changing the consequences of the risk;  sharing the risk with another party (e.g. contractor);  retaining the risk by informed decision.
  • 13. Risk management for new product manufacturing Risk management for Site Transfer Product manufacturing Risk Management for Aseptic Manufacturing Process
  • 14.  FMEA format and shall be based on the potential variables that can affect Sterility Assurance of Product, Endotoxin level, Particulate count. (For us vaccine safety, efficacy, purity)  The risk assessment shall be based on personnel, material, equipment, components, environment and utility control. (5 M)  Critical parameter such as aseptic process simulation (media fill), smoke test study, personnel, environment, material movement, process, equipments, utility and any direct impact on aseptic process/sterility assurance shall be considered. Risk Management for Aseptic Manufacturing Process
  • 15.  Incidents/events, Market complaints, Batch failure investigations, process / Analytical trend monitoring, Audits, Change control related to aseptic manufacturing process shall be reviewed as a part of risk assessment process to identify the potential variables that can affect sterility assurance of product, endotoxin level, particulate count and ultimately the risk at the end use.  The risk assessment reports shall be prepared by concerned department, reviewed by concerned department head to which the risk is concerned and approved by QA.  Subsequent to process validations, Critical Quality attributes (CQA) shall be monitored through APR. based on the frequent failure in controlled system Risk Assessment is to be revised.
  • 16.  Give the number of risk assessment in the format of HBL/RA/00N/YY 00N is serial number of Risk Assessment & YY is revision number of RA. If its first version then no need to mention it.  Title of Risk assessment : Title of Risk Assessment for which number is to be assigned.  Type of Risk assessment : The type for which risk assessment is assigned shall be mentioned. Type includes Product / System / Equipment / Instrument / Machine / Utility/ Material / Other.  Risk assessment Number : Allotted number to be shall be mentioned.  Effective on : Date on which the risk assessment report is approved shall be mentioned.  Year : Year of risk assessment number allocation shall be mentioned.  Remarks : Remark shall be written if any. In case of no remark “None” shall be recorded. Procedure for risk assessment document numbering
  • 17.
  • 18. Three factors shall be considered when assessing the level of risk  Severity / Impact of Risk  Probability of Occurrence  Probability of Detection (State of Controls) S O C
  • 19. SEVERITY Quantitative Rating Qualitative Rating Criteria 1-2 (Low) Low · No impact on product identity, strength, purity and quality · Minor GMP non-compliance · No impact on user safety (defects which may not pose any significant hazard to health) 3-4 (Medium) Medium · Likely impact on product identity, strength, purity and quality · Major GMP non-compliance · Potential impact on user safety (defects which could cause illness or mistreatment but are not life threatening or serious ones or are medically Reversible) 5-6 (High) High · Direct impact on product identity, strength, purity and quality · Critical GMP non-compliance · Critical impact on user t safety (defects which are potentially life-threatening or could cause serious risk to health) Severity Assessment
  • 20. Example of the Risk Assessment of Initiation of Deviation
  • 21.
  • 22. Assessment of Probability of Occurrence (O) of the Cause PROBABILITY OF OCCURRENCE Quantitative Rating Qualitative Rating Criteria 1-2 (Low) Low The quality related event is unlikely to occur. (i.e. it has not occurred in the past and is not expected to occur or recur) 3-4 (Medium) Medium The quality related event may occur (i.e. It has occurred infrequently in the past and is expected to recur) 5-6 (High) High The quality related event is likely to occur (i.e. it has occurred in the past on a frequent basis and is definitely expected to occur again).
  • 23. Example of the Risk Assessment of Initiation of Deviation
  • 24. Risk rating based on probability of occurrence Risk rating based on severity Low Medium High NA High Level-1 Level-1 Level-1 Level-1 Medium Level-2 Level-2 Level-1 Level-2 Low Level-3 Level-3 Level-2 Level-3 NA Level-3 Level-3 Level-2 NA
  • 25. Assessment of the ‘Probability of Detection (D) (or ‘State of Control’) DETECTION Quantitative Rating Qualitative Rating Criteria 5-6 (Weak) Weak The Quality System has either ‘weak’ or ‘no’ controls to detect the quality related event after its occurrence and prevent it from recurring, e.g. systems are non validated or with perception based evaluation techniques, process controls are dependent on human efficiency, etc. There is a low chance the current controls will detect the quality event after its occurrence. 3-4 (Medium) Medium The system has controls and will possibly detect the quality related event after its occurrence. 1-2 (Strong) Strong The system has multiple controls and is very likely to detect the quality related event after its occurrence.
  • 26.
  • 27. Final Risk Classification Rating – Probability of Detection Risk level based on severity & probability of occurrence Strong Medium Weak NA Level-1 Major Critical Critical Critical Level-2 Minor Major Critical Critical Level-3 Minor Minor Major Major NA Un-classified Un-classified Un-classified Un-classified
  • 28. Significance of Risk Priority Number (RPN = SxOxD ) Risk Priority Number Risk Category Nature of impact Acceptance criteria & Mitigation (action) statusRisk on Product Risk on people/ Facility/ Organization < 20 < 25 Minor Non impact Risk is acceptable. No mitigation is required < 60 < 75 Major Indirect impact Acceptable with control /explanation of control. ≥ 60 ≥ 75 Critical Direct Impact Requires additional control measure before acceptance Risk Evaluation
  • 29.  Is the risk above an acceptable level?  What can be done to reduce or eliminate risks?  What is the appropriate balance among benefits, risks and resources?  Are new risks introduced as a result of the identified risks being controlled? Risk Control/ Mitigation Control Measures/CAPA shall be considered for risk control/ mitigation and shall be implemented using applicable procedures for the same. Such actions shall be prioritized to control/ mitigate the risk or reduce it to an acceptable level.
  • 30. Assessment of Risk Level and Its Mitigation Sr.No Potential Failure Mode/ Type of problem RPN Number Level of Risk Risk Mitigation Reference Document No 1. GMP document is to be prepare in A4 size paper approved uniform format. 3 Minor NA Process is under Control NA 2. SOP is to be clear, unambiguous language, easy to understand and easy to follow. 12 Minor 3. Concerned department person has to filled Change control form for the preparation of the new GMP document. 3 Minor 4. For the preparation of the GMP document Draft copy is to be prepared and send to Quality assurance department for review. 3 Minor 5. Subject matter expert from the concerned department can prepare SOP if he or she is trained for the SOP. Officer, executive or concerned person who has expertise in subject of SOP can review and signed as checked by. 9 Minor 6. GMP document numbering is to be done by Quality Assurance department and as per the Master Document numbering guide. 9 Minor 7. Once the document is reviewed and approved and respective change control is closed then QA person will stamp signed and approved GMP document as Master Copy in red color at the bottom right corner and retain it as Master in QA document archival. 6 Minor 8. QA person will make the no of required photocopies of the GMP document from the Master Copy and stamp as CONTROLLED COPY or UNCONTROLLED COPY as required for issuance. 2 Minor 9. In case of the GMP records QA person will take print in black and white and stamp as CONTROLLED COPY or UNCONTROLLED COPY for issuance. 2 Minor 10 If any change is required in the GMP document, concerned person will fill change control and follow the change control procedure. 45 Major SOP HBl-QAD-1001-01-02 is to be revised Controlled copy must be photocopied of the scan signed approved master copy. Each issued controlled copy of record must have identification number. Ref CAPA : _______
  • 31.
  • 32. Risk Reduction may be achieved by (but not limited to):  Improvement in the quality of the product by design - this may include improvement in the process, procedures, control measures, monitoring.  Change of process and / or procedures.  Revision of specification to stringent limits.  Improvement of periodicity of the measurement of parameters.  Change in the frequency of calibration, qualification, validation, quality system internal audits in order to proactively identify the chances of the risk. Risk Reduction
  • 33. Risk assessment tools Following risk assessment tools can be used for performing risk assessment, but not limited to:  Flow Charting  Brainstorming  Process Mapping  Statistical Tools  Risk Ranking & Filtering  Preliminary Hazard Analysis (PHA)  Root Cause Analysis  Ishikawa or Fish Bone Diagrams  FMEA (Failure Mode and Effects Analysis)/FMECA (Failure Mode Effects and Criticality Analysis)  HACCP (Hazard Analysis and Critical Control Points)  Variation Risk Management  Probabilistic Risk Analysis  Decision Trees  Event Tree Analysis  FTA (Fault Tree Analysis)
  • 34. QUALITY SYSTEMS FOR WHICH RISK ASSESSMENT IS TO BE PERFORMED Sr.No Risk Assessment is to be Performed Department/Section TCD 1 Deviation Handling Procedure Quality Assurance 2 Change Control Procedure Quality Assurance 3 DocumentationSystem Quality Assurance 4 Vendor Audit & Approval Quality Assurance
  • 35. EQUIPMENT & UTILITY FOR WHICH RISK ASSESSMENT IS TO BE PERFORMED Sr.No Risk Assessment is to be Performed Department/Section TCD 1 Water System Engineering 2 PSG Engineering 3 Compressed Air Engineering 4 Autoclave Engineering 5 DHS Engineering 6 Incubator Engineering 7 Lyophilizer Engineering